The German harmonization study Scheel et al. [20] also showed for non-small cell lung cancer (NSCLC) that the anti-PD-L1 antibodies clone 22C3 and clone 28-8 provide comparable results. This evidence concerns the gene CD274 and non-small cell lung carcinoma.